PaulMHassounMD
Pulmonology • Baltimore, MDCritical Care Medicine, Pleural Disease
Professor of Medicine, Johns Hopkins University School of Medicine; Director, Pulmonary Hypertension Program
Dr. Hassoun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 North Caroline Street
Baltimore, MD 21287Phone+1 410-550-5864Fax+1 410-367-2014
Education & Training
Tufts Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1988
Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 1984 - 1987
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1981 - 1984
University of Paris VII Faculty of MedicineClass of 1981
Certifications & Licensure
MD State Medical License 2002 - 2026
MA State Medical License 1983 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis Start of enrollment: 2010 Jan 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsGuidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American So...Monica Mukherjee, Lawrence G Rudski, Karima Addetia, Jonathan Afilalo, Michele D'Alto
Journal of the American Society of Echocardiography. 2025-03-01 - Alterations in Mitochondrial Function in Pulmonary Vascular Diseases.Samar Farha, Kewal Asosingh, Paul M Hassoun, John Barnard, Suzy Comhair
Antioxidants & Redox Signaling. 2025-03-01 - Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients.Franck F Rahaghi, Marc Humbert, Marius M Hoeper, R James White, Robert P Frantz
The Lancet. Respiratory Medicine. 2025-02-20
Press Mentions
Pulmonary Arterial Hypertension: Critical Observations in Pulmonary Medicine, Ep. 3April 21st, 2022
The Key Laboratory of Pulmonary Vascular Medicine, Chinese Academy of Medical Sciences (KLPVM-CAMS): A Medical Centre Focusing on Clinical, Translational and Basic Research, Whose Mission Is to Improve the Outcome of Patients with Pulmonary Vascular Di...December 21st, 2019
Pulmonary Vascular Disease Phenomics Program PVDOMICS (PVDOMICS)January 13th, 2017
Grant Support
- Mechanisms of Right Ventricular Dysfunction in Scleroderma-associated PAHJOHNS HOPKINS UNIVERSITY2012–2025
Other Languages
- French, Arabic
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/paul-hassoun
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
